Stefanie Dimmeler

Director of the Institute of Cardiovascular Regeneration; University of Frankfurt
Dr. Stephanie Dimmeler, Ph.D. is the Founder of t2cure GmbH. Dr. Dimmeler has been Professor of Experimental Medicine, Director of the Institute of Cardiovascular Regeneration and head of the Section of Molecular Cardiology at the University of Frankfurt (Germany) since 2001. She is on the Editorial Board of The Journal of Clinical Investigation, Circulation, Circulation Research and others. She is co-founder of the European Network of Excellence "Vascular Genomic Network (EVGN)" supported by the European Community and Co-Director of the Transatlantic Network of Cardiac Regeneration supported by the Leducq Foundation. She has been a Member of Scientific Advisory Board of miRagen Therapeutics, Inc. since January 2010.

Dr. Dimmeler serves as a Member of the Advisory Board of t2cure GmbH. Her research is predominantly focused on endothelial cell biology, including signal transduction, apoptosis, and renewal by circulating endothelial progenitor cells in health and disease. Prof. Dr. Dimmeler has published more 150 papers with a global impact factor of higher than 900. She presented the prestigious George E. Brown Memorial Lecture at the Scientific Sessions of the AHA in 2005 and the Basic Science Lecture of the European Society of Cardiology in 2006. She identified novel signaling pathways mediating the synthesis and release of the endothelial protective factors NO. Together with Dr. Zeiher, she has been translating science from bench to bedside culminating in current clinical trials of human progenitor cells for cardiovascular repair. She received several of the most prestigious awards including the Award of the German Heart Foundation in 1998, the Frankel-Award of the German Cardiac Society in 2000, the prestigious Alfried Krupp Award 2002, the Leibniz Award 2005, the FEBS award 2006, and together with Professor Zeiher and Professor Penninger the E. Jung Award.

Visit Stefanie's Lab